EBS
Emergent Biosolutions IncNYSE
Healthcare • Drug Manufacturers - Specialty & Generic
Factor tilt: Small-Cap Blend
$6.06+3.59%
Close Nov 6, 2026
- Market cap
- $312.67M
- 1 month
- -11.0%
- 3 months
- +35.6%
- 1 year
- -41.4%
- 52-week range
- $4.45$13.90
- Dividend
- No dividends on record
- Short interest
- 19.7% of float9.7M shares · settled Oct 15, 2026 · +4.2% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Sep 30, 2026
- Revenue
- $649.1M
- Net income
- -$260.7M
- Free cash flow
- $188.4M
- Book value
- $313.2M
- Total debt
- $507.7M
- P/E
- —
- Price / sales
- 0.5×
- Price / book
- 1×
- FCF yield
- +60.3%
- Net margin
- -40.2%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Emergent Biosolutions Inc
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments.
Read more
The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
- Website
- emergentbiosolutions.com
- Headquarters
- Gaithersburg, MD, United States
- Employees
- 900
- Listed
- Nov 15, 2006
- Fiscal year ends
- December
Company profile from EODHD, stored Nov 5, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Sep 2026filed Nov 3, 2026 | $110.0M | -52.4% | 16.9% | -$37.3M | -$32.7M |
| Jun 2026filed Aug 6, 2026 | $234.3M | +66.3% | 58.6% | -$125.1M | -$180.2M |
| Mar 2026filed Apr 30, 2026 | $156.1M | -29.7% | 43.3% | $10.5M | $6.8M |
| Dec 2025filed Feb 27, 2026 | $148.7M | -23.6% | 31.3% | -$16.6M | -$54.6M |
| Sep 2025filed Oct 30, 2025 | $231.1M | -21.3% | 55.9% | $76.8M | $51.2M |
| Jun 2025filed Aug 7, 2025 | $140.9M | -44.7% | 40.8% | $500.0K | -$12.0M |
| Mar 2025filed May 8, 2025 | $222.2M | -26.0% | 52.4% | $48.6M | $68.0M |
| Dec 2024filed Mar 4, 2025 | $194.7M | -29.6% | 70.1% | -$9.5M | -$31.3M |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Feb 27, 2026 | $742.9M | -28.8% | 47.2% | $110.2M | $52.6M |
| Dec 2024filed Mar 4, 2025 | $1.0B | -0.5% | 36.0% | -$108.7M | -$190.6M |
| Dec 2023filed Mar 8, 2024 | $1.0B | -6.1% | 34.3% | -$726.4M | -$760.5M |
| Dec 2022filed Mar 1, 2023 | $1.1B | -37.0% | 42.3% | -$170.0M | -$211.6M |
| Dec 2021filed Feb 25, 2022 | $1.8B | +12.4% | 44.7% | $341.4M | $219.5M |
| Dec 2020filed Feb 19, 2021 | $1.6B | +42.6% | 54.7% | $438.5M | $305.8M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched EBS. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
9,684,744 shares short
+390,758 shares (+4.2%) vs Sep 30, 2026
19.7% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
9,293,986 shares short
-492,394 shares (-5%) vs Sep 15, 2026
18.9% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
9,786,380 shares short
-1,055,855 shares (-9.7%) vs Aug 31, 2026
Share of float unavailable. Published Sep 24, 2026.
Settlement Aug 31, 2026
10,842,235 shares short
-798,323 shares (-6.9%) vs Aug 14, 2026
21.4% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
11,640,558 shares short
+1,611,388 shares (+16.1%) vs Jul 31, 2026
23% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
10,029,170 shares short
-309,867 shares (-3%) vs Jul 15, 2026
19.8% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind EBS’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
No qualified split events are stored. This does not establish that the stock has never split.
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if EBS is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
21 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Nov 5, 2026
Smart-money 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: neutral
Last trade: sell 31 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 2
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
194 filers reported a long position in EBS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
50.2%
of the 44.6M shares 13-F filers reported
Moves vs Q1 2026
6 added3 trimmed
1 unchanged
Net shares held
+7.6%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $39.5M · 4.7M shares | 4.7M | +8.6% |
| 2 | DIMENSIONAL FUND ADVISORS LP | $25.8M · 3.1M shares | 3.1M | +11.6% |
| 3 | STATE STREET CORP | $24.6M · 2.9M shares | 2.9M | +2.8% |
| 4 | AMERICAN CENTURY COMPANIES INC | $23.2M · 2.8M shares | 2.8M | +14.2% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $18.4M · 2.2M shares | 2.2M | -2.6% |
| 6 | LSV ASSET MANAGEMENT | $14.2M · 1.7M shares | 1.7M | +89.1% |
| 7 | ACADIAN ASSET MANAGEMENT LLC | $11.3M · 1.3M shares | 1.3M | -2.7% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | $11.2M · 1.3M shares | 1.3M | +5.1% |
| 9 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10.1M · 1.2M shares | 1.2M | -20.3% |
| 10 | OAK HILL ADVISORS LP | $9.3M · 1.1M shares | 1.1M | Unchanged |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of EBS file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 14, 2026 | AMERICAN CENTURY INVESTMENT MANAGEMENT INC13G · passive | 5.4% |
| Jul 31, 2026 | VANGUARD CAPITAL MANAGEMENT LLC13G · passive · amended | 4.92%under 5% |
| Jul 28, 2026 | BlackRock, Inc.13G · passive · amended | 9% |
| Apr 9, 2026 | DIMENSIONAL FUND ADVISORS LP13G · passive | 5.3% |
| Mar 26, 2026 | VANGUARD GROUP INC13G · passive · amended | 0%under 5% |
Get the Full Analysis for EBS
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.